Japanese technology conglomerate SoftBank Group Corporation is “exploring” either selling or floating British chip designer Arm Holdings, which it bought four years ago for $32bn, say Dana Cimilluca and Cara Lombardo in The Wall Street Journal. The review is at an “early stage”, so it is possible that SoftBank will “ultimately choose to do nothing”.
However, a sale would help it raise cash to “mollify” activist investor Elliott Management, which has been “agitating for changes at the company”. This money could be used to buy back its own shares, which trade at a “steep discount relative to net asset value”.
Good luck getting much cash for Arm Holdings, says Alec Macfarlane on Breakingviews. While SoftBank’s CEO, Masayoshi Son, once called Arm Holdings his “most important acquisition”, he may struggle to get buyers to feel the same way. Despite Arm Holdings splurging on research and development spending, making big acquisitions and going on a “hiring spree”, sales have failed to take off, growing by a “paltry” 2% in the fiscal year to March. Industry tracker IDC forecasts that shipments this year will decline by 12% amid Covid-19 disruptions, hinting at “further pain to come”. With rival chipmaker Intel trading at around three times historical sales, Arm Holdings could be worth as little as $6bn.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Still, even if getting rid of it proves more difficult than expected, SoftBank may not need to sell it, since the conglomerate has already managed to sell a lot of assets over the past few months, say Arash Massoudi and Kana Inagaki in the Financial Times.
SoftBank managed to raise $23.2bn last month from selling its stake in the company created by the merger of Sprint with T-Mobile. SoftBank has also sold down its holdings in Chinese ecommerce group Alibaba, which has hit “record after record” this year. As a result, it is already 90% of the way towards its goal of raising $41bn.
WeWork is working better
Even SoftBank’s most controversial investment, shared-workspace provider WeWork, is looking better these days, says Catherine Shu on TechCrunch. Thanks to financial and management issues that led to the resignation of founder Adam Neumann, WeWork’s valuation plunged from as much as $47bn at the beginning of 2019 to $2.9bn in March, leading to an overall $24bn loss for SoftBank. However, thanks to “aggressive cost-cutting measures”, which have reduced WeWork’s headcount from 14,000 to 5,600, and the sale of several of its businesses, WeWork now expects positive cash flow in 2021.
No wonder, then, that SoftBank’s shares “have more than doubled from their March low”, increasing Son’s personal fortune to $20bn, says Bloomberg. The bounce could endure. Earnings are set to recover from last quarter’s “record loss”, while short-sellers are under pressure to “cover losing bets”.
-
Is the AI boom another dotcom bubble?25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
-
What is the S&P 500?The S&P 500 is one of the world’s most popular stock market indices and has almost tripled in value over the last decade. But what is the S&P 500, and which companies does it contain?
-
Why CEOs deserve a pay riseOpinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
-
Rolls-Royce stock jumps 15% – could it climb further?Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
-
The power of private marketsInterview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseasesVertex Pharmaceuticals operates in a profitable subsector and is poised for further success
-
Global investors have overlooked these top tips in emerging marketsOpinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
-
King Coal has not been dethroned yet — should you buy?The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
-
It’s time to start buying Europe again, says Merryn Somerset WebbOpinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fadesFood-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
